|
|
|
|
Direct Cost |
Indirect Cost |
|
| 1DP1CA290976-01A1 |
Immune drivers of oncogenic virus progression to cancer in people living with HIV |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$350,000 |
$194,250 |
$544,250 |
| 1K23AR085189-01 |
Inflammatory Responses, Fibrotic Mediators, and Comorbidity Burden as Determinants of Myocardial Dysfunction and Heart Failure in Rheumatoid Arthritis |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIAMS |
$159,291 |
$12,743 |
$172,034 |
| 1R01CA288372-01A1 |
Targeting Disease Specific Tn Antigen in Pancreatic Cancer |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$117,777 |
$0 |
$117,777 |
| 1R01CA295693-01 |
Porcine Platforms For Technology Development In Pancreatic Cancer |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$414,169 |
$221,580 |
$635,749 |
| 1R01DA059874-01A1 |
Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIDA |
$793,700 |
$104,325 |
$898,025 |
| 1R01DA062274-01 |
Molecular interplay of HIV Tat, cocaine, and cART in microglial pyroptosis: Role of NLRP3 inflammasome |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIDA |
$319,330 |
$170,842 |
$490,172 |
| 1R01DA064132-01 |
Synergistic Effect of Nicotine and Antiretrovirals on Placental Development |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIDA |
$467,996 |
$250,378 |
$718,374 |
| 1R01DE034088-01A1 |
Molecular Mechanism by which Notch Signaling regulates TMJ Osteoarthritis |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIDCR |
$273,211 |
$146,168 |
$419,379 |
| 1R01EB035543-01A1 |
Theory Assisted Design, Synthesis and Biological Activity of Bacteria-Targeting Nanostructures |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIBIB |
$297,380 |
$113,333 |
$410,713 |
| 1R01EY036404-01A1 |
Molecular approach to ameliorate the age-dependent loss of Clock protein Bmal1 and Nrf2-antioxidant response in eye lens: Implications for eye lens health span |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NEI |
$250,400 |
$133,964 |
$384,364 |
| 1R01HD116950-01 |
RBC transfusion exacerbates brain inflammation in anemic murine neonates and causes long term neurodevelopment impairment |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NICHD |
$190,381 |
$101,854 |
$292,235 |
| 1R01NS137084-01A1 |
Contribution of Glia to Sleep/Wake Disturbances in FXS |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NINDS |
$349,714 |
$166,184 |
$515,898 |
| 1R03CA297351-01 |
Silencing B7-H3 mitigates tumor aggressiveness in group 3 medulloblastoma |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$50,000 |
$26,750 |
$76,750 |
| 1R21AI185574-01A1 |
Adaptation of an in vitro generated human skin model for tick feeding to study Borrelia burgdorferi transmission and colonization |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIAID |
$275,000 |
$142,845 |
$417,845 |
| 1R21AI188168-01A1 |
Mechanism of Dynein-mediated Early Intracellular Trafficking of Human Papillomavirus |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIAID |
$150,000 |
$80,250 |
$230,250 |
| 1R21AI193368-01 |
Identifying novel immune determinants that influence S. aureus biofilm infection using Collaborative Cross (CC) mouse lines |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIAID |
$275,000 |
$142,845 |
$417,845 |
| 1R21CA297629-01A1 |
Co-targeting IGF-1R and Glutaminase in Ewing Sarcoma |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$257,125 |
$134,061 |
$391,186 |
| 1R21CA298918-01 |
Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NCI |
$116,875 |
$62,528 |
$179,403 |
| 1R21EB036228-01A1 |
A novel and efficacious electrotaxis system for enhancing chronic wound healing |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NIBIB |
$283,630 |
$151,742 |
$435,372 |
| 1R21EY037036-01 |
Using optical sensors to measure synaptic glutamate release from retinal rod photoreceptor cells |
UNIVERSITY OF NEBRASKA MEDICAL CENTER |
NEI |
$125,000 |
$65,538 |
$190,538 |